Literature DB >> 23923076

Butyrate alleviates metabolic impairments and protects pancreatic β cell function in pregnant mice with obesity.

Hua-Ping Li1, Xuan Chen, Ming-Qing Li.   

Abstract

The relative or absolute deficiency of pancreatic β-cell mass function underlies the pathogenesis of diabetes. It is necessary to alleviate the metabolic stress and reduce the demand for insulin to decrease the effects of mutations affecting β-cell expansion. Butyrate is a natural nutrient existed in food and can also be produced physiologically through the intestinal fermentation of fiber. Pregnancy and obesity model would be helpful for understanding how β-cell adapt to insulin resistance and how butyrate alleviate the metabolic impairment and protect pancreatic β cell function in pregnant mice with obesity. C57BL/6J female mice were divided into three groups and fed with high fat food (HF group, 40% energy from fat), high fat with sodium butyrate food (HSF group, 95% HF with 5% butyrate), or control food (CF group, 14% energy from fat), respectively. The feeding would last for 14 weeks before mating and throughout the gestation period. A subset of dams were sacrificed at gestational day (GD) 14.5 to evaluate the changes of metabolism and β-cell function, mass, proliferation and apoptosis, inflammatory reaction of islet from different diet. Pancreases were double immuno-labeled to assess the islet morphology, insulin expression, expression of proliferation gene PCNA and anti-apoptosis gene bcl-2. Moreover, we detected the expression of NF-κB, phosphorylated NF-κB (pNF-κB) to evaluate the islet inflammatory response with immunohistochemistry. Mice fed with HSF showed obviously changes including the decreased values of weight gain, glucose, insulin, triglyceride and total cholesterol level of blood compared with high fat diet group, and the reduced circulating maternal pro-inflammation factors at GD14.5. Mice fed with HF displayed β-cell hyperplasia with a greater β-cell size and β-cell area in pancreas. Furthermore, the higher ratio of apoptosis and inflammatory response were found in HF group compared with HSF and CF group, while the proliferation rates of β-cell increased in HF group, but not in HSF or CF. Butyrate shows an obvious function of anti-obesity, and can alleviate the metabolic stress, maintain the β-cell function and protect them from inflammatory response in pregnant obese mouse without obvious fetus toxicity.

Entities:  

Keywords:  GDM; Sodium butyrate; diabetes; pancreatic islet; β-cell

Mesh:

Substances:

Year:  2013        PMID: 23923076      PMCID: PMC3726973     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  40 in total

Review 1.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

Review 2.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.

Authors:  Miriam Cnop; Nils Welsh; Jean-Christophe Jonas; Anne Jörns; Sigurd Lenzen; Decio L Eizirik
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  Low insulin content of large islet population is present in situ and in isolated islets.

Authors:  Han-Hung Huang; Lesya Novikova; S Janette Williams; Irina V Smirnova; Lisa Stehno-Bittel
Journal:  Islets       Date:  2011 Jan-Feb       Impact factor: 2.694

4.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

Review 5.  Fatty acid signaling in the beta-cell and insulin secretion.

Authors:  Christopher J Nolan; Murthy S R Madiraju; Viviane Delghingaro-Augusto; Marie-Line Peyot; Marc Prentki
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

6.  Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes.

Authors:  Hyeon-Sook Suh; Shinyeop Choi; Pallavi Khattar; Namjong Choi; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-17       Impact factor: 4.147

Review 7.  Glucolipotoxicity of the pancreatic beta cell.

Authors:  Vincent Poitout; Julie Amyot; Meriem Semache; Bader Zarrouki; Derek Hagman; Ghislaine Fontés
Journal:  Biochim Biophys Acta       Date:  2009-08-26

8.  Butyrate regulates leptin expression through different signaling pathways in adipocytes.

Authors:  Mohamed Mohamed Soliman; Mohamed Mohamed Ahmed; Alaa-Eldin Salah-Eldin; Abeer Abdel-Alim Abdel-Aal
Journal:  J Vet Sci       Date:  2011-12       Impact factor: 1.672

9.  Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.

Authors:  Hua V Lin; Andrea Frassetto; Edward J Kowalik; Andrea R Nawrocki; Mofei M Lu; Jennifer R Kosinski; James A Hubert; Daphne Szeto; Xiaorui Yao; Gail Forrest; Donald J Marsh
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

Review 10.  NF-kappaB regulation: the nuclear response.

Authors:  Arun K Mankan; Matthew W Lawless; Steven G Gray; Dermot Kelleher; Ross McManus
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more
  15 in total

Review 1.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

Review 2.  Physiological effects of nutrients on insulin release by pancreatic beta cells.

Authors:  Monica Losada-Barragán
Journal:  Mol Cell Biochem       Date:  2021-04-12       Impact factor: 3.396

3.  Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.

Authors:  V A Matheus; Lcs Monteiro; R B Oliveira; D A Maschio; C B Collares-Buzato
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-15

Review 4.  Microbial transmission from mothers with obesity or diabetes to infants: an innovative opportunity to interrupt a vicious cycle.

Authors:  Taylor K Soderborg; Sarah J Borengasser; Linda A Barbour; Jacob E Friedman
Journal:  Diabetologia       Date:  2016-02-02       Impact factor: 10.122

Review 5.  Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature.

Authors:  Muhammad Jaffar Khan; Konstantinos Gerasimidis; Christine Ann Edwards; M Guftar Shaikh
Journal:  J Obes       Date:  2016-09-15

6.  ZiBuPiYin recipe improves cognitive decline by regulating gut microbiota in Zucker diabetic fatty rats.

Authors:  Chunyan Gu; Wen Zhou; Wang Wang; Hong Xiang; Huiying Xu; Lina Liang; Hua Sui; Libin Zhan; Xiaoguang Lu
Journal:  Oncotarget       Date:  2017-04-25

7.  Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?

Authors:  Jamie Joseph; Colin Depp; Pei-An B Shih; Kristen S Cadenhead; Geert Schmid-Schönbein
Journal:  Front Neurosci       Date:  2017-03-27       Impact factor: 4.677

Review 8.  Non-alcoholic fatty liver disease, diet and gut microbiota.

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  EXCLI J       Date:  2014-05-07       Impact factor: 4.068

9.  Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice.

Authors:  Jian Hong; Yimin Jia; Shifeng Pan; Longfei Jia; Huifang Li; Zhenqiang Han; Demin Cai; Ruqian Zhao
Journal:  Oncotarget       Date:  2016-08-30

10.  Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.

Authors:  Anja Baumann; Cheng Jun Jin; Annette Brandt; Cathrin Sellmann; Anika Nier; Markus Burkard; Sascha Venturelli; Ina Bergheim
Journal:  Nutrients       Date:  2020-03-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.